← IndicationsOpen filtered programs
Landscape
Tinnitus
Tinnitus has 104 tracked records across 44 named organizations, including 14 strong-evidence records and 21 active programs. Records with caveats and trial-derived candidates remain visible for deeper review.
104
Pipeline Records
strong evidence + caveats + candidates
14
Strong Evidence
90 checked records with caveats
21
Active Programs
currently active
18
Marketed / Approved
commercial or approved
44
Organizations
companies, sponsors, and institutions
Competitive Density
100/100
organization breadth + program volume
Pipeline Velocity
25/100
active and late-stage share
Evidence Coverage
13/100
share strong evidence
Completion Signal
54/100
late-stage, approved, or marketed
Attrition Rate
10/100
share discontinued
Concentration
50/100
top-organization share
Programs by Stage
Early Phase 12 · 2%
Phase 112 · 12%
Phase 220 · 19%
Phase 2/32 · 2%
Phase 38 · 8%
Phase 410 · 10%
Interventional/NA9 · 9%
Marketed20 · 19%
Observational/NA2 · 2%
Not applicable19 · 18%
Trial / Program Status
Active21 · 20%
Marketed18 · 17%
Completed43 · 41%
Discontinued10 · 10%
Paused1 · 1%
Unknown11 · 11%
Modality Breakdown
Small Molecule44 · 42%
Neuromodulation19 · 18%
Steroid/Anti-inflammatory9 · 9%
Hearing Aid/Software5 · 5%
Behavioral/Rehabilitation4 · 4%
Biologic2 · 2%
Clinical Assessment/Endpoint2 · 2%
Diagnostic2 · 2%
Non-invasive Neuromodulation2 · 2%
Procedure/Rehab2 · 2%
Program Types
Therapeutic60 · 58%
Software/Neurotech21 · 20%
Procedure/Rehab11 · 11%
Device7 · 7%
Diagnostic5 · 5%
Top Organizations
Institution-led study52 · 50%
Investigator-led study6 · 6%
Beltone2 · 2%
Government-led study2 · 2%
Institution-led study cluster2 · 2%
Otonomy2 · 2%
Altamira Therapeutics1 · 1%
Applied Biology, Inc.1 · 1%
Population Tags
adult102 · 98%
tinnitus94 · 90%
sound-therapy19 · 18%
noise-induced10 · 10%
sensorineural10 · 10%
hearing-aid-feature8 · 8%
sudden7 · 7%
mobile-app6 · 6%
repurposed-drug6 · 6%
age-related5 · 5%
Strong-Evidence Programs
14 recordsLenire Tinnitus Treatment DeviceStrong evidence
Company: Neuromod Devices · Marketed · Marketed
NeuromodulationMarketedMarketed97% confidence
AC102 by AudioCure PharmaStrong evidence
Company: AudioCure Pharma · Phase 2 · Active
Small MoleculePhase 2Active91% confidence
Auricle Tinnitus DeviceStrong evidence
Company: Auricle Inc. · Phase 2 · Active
NeuromodulationPhase 2Active90% confidence
SPI-1005 by Sound PharmaceuticalsStrong evidence
Company: Sound Pharmaceuticals · Phase 3 · Active
Small MoleculePhase 3Active90% confidence
Neuromonics Tinnitus Treatment SystemStrong evidence
Company: Neuromonics · Marketed · Marketed
NeuromodulationMarketedMarketed88% confidence
Tinearity G1 Tinnitus SystemStrong evidence
Company: Duearity · Marketed · Marketed
NeuromodulationMarketedMarketed86% confidence
Beltone Serene Hearing AidsStrong evidence
Company: Beltone · Marketed · Marketed
Hearing Aid/SoftwareMarketedMarketed86% confidence
Signia Notch TherapyStrong evidence
Company: Signia · Marketed · Marketed
NeuromodulationMarketedMarketed85% confidence
ELEHEAR Beyond Pro OTC Hearing AidsStrong evidence
Company: ELEHEAR · Marketed · Marketed
Hearing Aid/SoftwareMarketedMarketed84% confidence
Widex Zen / SoundRelax Tinnitus Sound TherapyStrong evidence
Company: Widex · Marketed · Marketed
NeuromodulationMarketedMarketed84% confidence
Oticon Tinnitus SoundSupportStrong evidence
Company: Oticon · Marketed · Marketed
NeuromodulationMarketedMarketed84% confidence
ReSound Relief AppStrong evidence
Company: ReSound · Marketed · Marketed
NeuromodulationMarketedMarketed84% confidence
Starkey Multiflex Tinnitus TechnologyStrong evidence
Company: Starkey · Marketed · Marketed
NeuromodulationMarketedMarketed84% confidence
Phonak Tinnitus BalanceStrong evidence
Company: Phonak · Marketed · Marketed
NeuromodulationMarketedMarketed82% confidence
Checked Records With Caveats
90 recordsOTO-313 by Otonomy
Company: Otonomy · Phase 2 · Discontinued
Small MoleculePhase 2Discontinued96% confidence
AM-101 by Auris Medical and Altamira
Company: Altamira Therapeutics · Phase 3 · Discontinued
Small MoleculePhase 3Discontinued93% confidence
NHPN-1010
Company: Otologic Pharmaceutics · Phase 1 · Completed
Small MoleculePhase 1Completed89% confidence
OTO-104 (dexamethasone) by Otonomy
Company: Otonomy · Phase 3 · Discontinued
Steroid/Anti-inflammatoryPhase 3Discontinued90% confidence
MedRx AVANT ARC
Company: MedRx · Marketed · Marketed
DiagnosticMarketedMarketed90% confidence
Oto Tinnitus Program & Skills App
Company: Oto Health · Marketed · Marketed
NeuromodulationMarketedMarketed85% confidence
MindEar / Tinnibot Tinnitus App
Company: MindEar · Marketed · Marketed
NeuromodulationMarketedMarketed84% confidence
SoundCure Serenade Tinnitus Treatment System
Company: SoundCure · Marketed · Discontinued
NeuromodulationMarketedDiscontinued82% confidence
Beltone Tinnitus Calmer App
Company: Beltone · Marketed · Marketed
NeuromodulationMarketedMarketed81% confidence
Unitron Tinnitus Masker
Company: Unitron · Marketed · Marketed
NeuromodulationMarketedMarketed80% confidence
Sonormed Tinnitracks / Meine Tinnitus App
Company: Sonormed · Marketed · Marketed
NeuromodulationMarketedMarketed77% confidence
AudioNotch Notched Sound Therapy
Company: AudioNotch · Marketed · Marketed
NeuromodulationMarketedMarketed76% confidence
Isosorbide Oral Solution by Lunan Better PharmaceuticalStatus caveat
Company: Lunan Better Pharmaceutical Co., Ltd. · Phase 2/3 · Active
Small MoleculePhase 2/3Active88% confidence
Neramexane by MerzStatus caveat
Company: Merz Pharmaceuticals GmbH · Phase 3 · Completed
Small MoleculePhase 3Completed86% confidence
Vestipitant tinnitus study by GSKStatus caveat
Company: GlaxoSmithKline · Phase 2 · Completed
Small MoleculePhase 2Completed90% confidence
SoundMind customized sound therapy tinnitus studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Completed
Digital Sound Therapy/RehabilitationNot applicableCompleted88% confidence
Nottingham Auditory Games for Tinnitus Training StudyStatus caveat
Sponsor / Institution: Institution-led study · Phase 1 · Completed
Behavioral/RehabilitationPhase 1Completed88% confidence
Regensburg rTMS tinnitus duration and frequency studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Completed
NeuromodulationNot applicableCompleted88% confidence
São Paulo topical lidocaine tinnitus studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Completed
Small MoleculeNot applicableCompleted88% confidence
tVNS and myofascial-release tinnitus study control armStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Active
Neuromodulation/Rehabilitation StudyNot applicableActive88% confidence